輕食日報 - 健康飲食指南 | 營養知識分享 | 低卡美味菜單

Evocalcet: A New Oral Calcimimetic for Dialysis ... | 合法藥品大搜索

Evocalcet: A New Oral Calcimimetic for Dialysis ...

由TAkizawa著作·2020·被引用8次—ItisthenewestcalcimimeticintheworldandwasdevelopedinJapanwiththeaimofresolvingtheissuesoftheupperGIeffects,drug–druginteractions,and ...

 Evocalcet: A New Oral Calcimimetic for Dialysis ...

Ther Apher Dial. 2020 Jun; 24(3): 248–257.

, 1 , 2 , 2 , 2 and 3 Tadao Akizawa

1 Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo Japan

Kazuaki Ikejiri

2 R&D Division, Kyowa Kirin Co., Ltd., Tokyo Japan

Yuichiro Kondo

2 R&D Division, Kyowa Kirin Co., Ltd., Tokyo Japan

Yuichi Endo

2 R&D Division, Kyowa Kirin Co., Ltd., Tokyo Japan

Masafumi ...

閱讀更多

evocalcet fda Evocalcet orkedia etelcalcetide 旁必福 Parsabiv 旁必福parsabiv 旁必福價格 Etelcalcetide Cinacalcet cinacalcet價錢 銳 克 鈣 售 價 evocalcet fda Evocalcet orkedia etelcalcetide 停敏錠類固醇 保樂康緩釋膠囊120公絲 Diltiazem 180mg 痔瘡塞劑拉肚子 赫士睿pump Cinolone 飯前 適維樂舒沛噴吸入劑 舒沛噴用途
Evocalcet: A New Oral Calcimimetic for Dialysis ... | 合法藥品大搜索
由 T Akizawa 著作 · 2020 · 被引用 8 次 — It is the newest calcimimetic in the world and was developed in Japan with the aim of resolving the issues of the upper GI effects, drug–drug interactions, and ... Read More
Pharmacodynamics of evocalcet for secondary ... | 合法藥品大搜索
由 T Shigematsu 著作 · 2019 · 被引用 11 次 — Multiple doses of evocalcet reduced intact PTH levels with a concomitant decrease in serum calcium levels. Evocalcet was well tolerated in SHPT ... Read More
Evocalcet | 合法藥品大搜索
由 T Akizawa 著作 · 被引用 8 次 — Patients with chronic kidney disease often develop secondary hyperparathyroidism (SHPT), marked by high levels of circulating parathyroid hormone (PTH) and ... Read More
Head | 合法藥品大搜索
由 M Fukagawa 著作 · 2018 · 被引用 38 次 — Keywords: Japan; cinacalcet; evocalcet; gastrointestinal; randomized controlled trial; secondary hyperparathyroidism. Copyright © 2018 ... Read More
Long | 合法藥品大搜索
由 K Yokoyama 著作 · 2019 · 被引用 15 次 — Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD), and as the disease progresses SHPT is ... Read More
Long | 合法藥品大搜索
由 K Yokoyama 著作 · 2019 · 被引用 15 次 — Evocalcet is a novel calcimimetic developed as an equally efficacious, but more tolerable, alternative to the currently available ... Read More
Evocalcet | 合法藥品大搜索
Evocalcet (trade name Orkedia) is a drug for the treatment of hyperparathyroidism. It acts as a calcium-sensing receptor agonist. Read More
Evocalcet | 合法藥品大搜索
Evocalcet is an orally available calcium receptor (CaR) modulator, with potential calcimimetic activity. Upon administration, evocalcet allosterically binds ... Read More
Evocalcet | 合法藥品大搜索
由 T Akizawa 著作 · 2020 · 被引用 8 次 — It is the newest calcimimetic in the world and was developed in Japan with the aim of resolving the issues of the upper GI effects, drug–drug ... Read More
Pharmacokinetics of evocalcet in secondary ... | 合法藥品大搜索
由 T Shigematsu 著作 · 2018 · 被引用 10 次 — Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan ... Read More
相關資訊整理

【福祿鈣片】缺鈣、齲齒

藥品名稱:福祿鈣片許可證字號:內衛藥製字第008220號許可證種類:製　劑適應症:缺鈣、齲齒劑型:藥品類別:醫師藥師藥劑生指示藥...

【銳克鈣錠75毫克】治療透析患者的次發性副甲狀腺機能亢進。

藥品名稱:銳克鈣錠75毫克許可證字號:衛署藥輸字第025140號許可證種類:製　劑適應症:治療透析患者的次發性副甲狀腺機能亢進。...

【旁必福注射液】PARSABIV適用於治療罹患慢性腎臟病 (CKD) 且接受血液透析之成人病人的次發性副甲狀腺機能亢進 (secondary HPT)。

藥品名稱:旁必福注射液許可證字號:衛部藥輸字第027639號許可證種類:製　劑適應症:PARSABIV適用於治療罹患慢性腎臟病(CKD)且...

【銳克鈣錠25毫克】治療透析患者的次發性副甲狀腺機能亢進。

藥品名稱:銳克鈣錠25毫克許可證字號:衛署藥輸字第025141號許可證種類:製　劑適應症:治療透析患者的次發性副甲狀腺機能亢進。...

【鈣易清膜衣錠25毫克】治療透析患者的次發性副甲狀腺機能亢進。

藥品名稱:鈣易清膜衣錠25毫克許可證字號:衛部藥製字第058545號許可證種類:製　劑適應症:治療透析患者的次發性副甲狀腺機能亢...